0000950170-24-063613.txt : 20240522 0000950170-24-063613.hdr.sgml : 20240522 20240522173014 ACCESSION NUMBER: 0000950170-24-063613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240522 DATE AS OF CHANGE: 20240522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berry Lance A CENTRAL INDEX KEY: 0001478716 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 24974516 MAIL ADDRESS: STREET 1: 5677 AIRLINE ROAD CITY: ARLINGTON STATE: TN ZIP: 38002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 471052611 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 ownership.xml 4 X0508 4 2024-05-21 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001478716 Berry Lance A C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 true false false false false Common Stock 2024-05-21 4 A false 15091 0.00 A 20676 D Stock Option (Right to Buy) 4.97 2024-05-21 4 A false 33260 0.00 A 2034-05-21 Common Stock 33260 33260 D Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. Includes 18,788 restricted stock units. The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. /s/ Lisa Taylor as Attorney-in-fact for Lance A. Berry 2024-05-22